RankAlpha logo
Back to Rankings

MNPR

Monopar TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Above peers
vs peer average
MNPR vs peer average
72/100
MNPR vs. peer average (A vs. B)
Grade spread
A 3 · B 2 · C 1 · D 1 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CATX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $410.57M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCATXPerspective Therapeutics
MNPR
Monopar Therapeutics
CATX
Perspective Therapeutics
Grade
A
D
Momentum
89
21
Value
41
42
Sentiment
-
78
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CATX

MNPR / CATX
Grade Position
Above peers
MNPR vs. peer average (A vs. B)
72/100
Momentum
89
MNPR
Value
41
CATX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MNPR
1
CATX
Perspective Therapeutics Inc Common
D
40/100
+3
2
NGNE
Neurogene Inc Common
B
80/100
+1
3
MYGN
Myriad Genetics Inc Common
F
20/100
+4
4
EOLS
Evolus Inc Common
A
100/100
Even
5
EPRX
Eupraxia Pharmaceuticals Inc Common
B
80/100
+1
CATX is the first peer returned for this comparison set.